Anti-Infective Drugs Market Global Report 2017
出 版 商：TBRC
出版日期：2017/07/17
頁 數：125頁
文件格式：PDF
價 格：
USD 4,000 (Single-User License)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
USD 6,000 (Multi-User License)
USD 8,000 (Global-User License)
USD 4,000 (Hard copy)
Companies in the anti-infective drugs market are very active with multiple strategic collaborations and agreements. Top companies in the anti-infective drugs market are strategically partnering and collaborating with other companies and government agencies to broaden their products, technologies and services.
The Anti-Infective Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs sector.
Reasons to Purchase
‧ Outperform competitors using accurate up to date demand-side dynamics information.
‧ Identify growth segments for investment.
‧ Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Stay abreast of the latest customer and market research findings
‧ Benchmark performance against key competitors.
‧ Develop strategies based on likely future developments.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Gain a global perspective on the development of the market.
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the anti-infective drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-infective drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
‧ The market characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
‧ The anti-infective drugs market section of the report gives context. It compares the anti-infective drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Anti-Infective Drugs Indicators Comparison.
‧ The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Antibiotics, Antivirals, Antifungals, Others (Antihelmethic, Antiprotozoal)
Companies Mentioned: Pfizer Inc., GlaxosmithKline, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, and Sanofi
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Anti-Infective Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
The Anti-Infective Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs sector.
Reasons to Purchase
‧ Outperform competitors using accurate up to date demand-side dynamics information.
‧ Identify growth segments for investment.
‧ Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Stay abreast of the latest customer and market research findings
‧ Benchmark performance against key competitors.
‧ Develop strategies based on likely future developments.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Gain a global perspective on the development of the market.
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the anti-infective drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-infective drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
‧ The market characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
‧ The anti-infective drugs market section of the report gives context. It compares the anti-infective drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Anti-Infective Drugs Indicators Comparison.
‧ The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Antibiotics, Antivirals, Antifungals, Others (Antihelmethic, Antiprotozoal)
Companies Mentioned: Pfizer Inc., GlaxosmithKline, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, and Sanofi
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Anti-Infective Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
1. Anti-Infective Drugs Market Characteristics;
2. Anti-Infective Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Anti-Infective Drugs Market Customer Information;
5. Anti-Infective Drugs Market Segmentation;
5.1. Global Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 5.2. Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Anti-Infective Drugs Market Trends And Strategies; 5.3 Global Anti-Infective Drugs Market Trends And Strategies;
6. Anti-Infective Drugs Market Regional And Country Analysis;
6.1. Global Anti-Infective Drugs Market, 2016, By Region; 6.2. Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Anti-Infective Drugs Market, 2016, By Country; 6.4. Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;
7. Global Anti-Infective Drugs Market Comparison With Macro Economic Factors;
7.1. Anti-Infective Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Anti-Infective Drugs Expenditure, Global;
8. Anti-Infective Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Anti-Infective Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Anti-Infective Drugs Expenditure, By Country;
9. Anti-Infective Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Anti-Infective Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Anti-Infective Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Anti-Infective Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Anti-Infective Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Hiv, 2014, By Country; 9.10. Global Number Of General Practitioners 2016, By Country; 9.11. Global Anti-Infective Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Anti-Infective Drugs Market;
10.1.1. Asia-Pacific Anti-Infective Drugs Market Overview; 10.1.2. Asia-Pacific Anti-Infective Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.2. Asia-Pacific Anti-Infective Drugs Market: Country Analysis; 10.3. China Anti-Infective Drugs Market; 10.3.1. China Anti-Infective Drugs Market Overview; 10.3.2. China Anti-Infective Drugs Historic Market, 2012 - 2016; 10.3.3. China Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.3.4. China Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.3.5. China Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 10.4. India Anti-Infective Drugs Market; 10.4.1. India Anti-Infective Drugs Market Overview; 10.4.2. India Anti-Infective Drugs Historic Market, 2012 - 2016; 10.4.3. India Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.4.4. India Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.4.5. India Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 10.5. Japan Anti-Infective Drugs Market; 10.5.1. Japan Anti-Infective Drugs Market Overview; 10.5.2. Japan Anti-Infective Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.5.5. Japan Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 10.6. Australia Anti-Infective Drugs Market; 10.6.1. Australia Anti-Infective Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.6.4. Australia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;
11. Western Europe Anti-Infective Drugs Market;
11.1.1. Western Europe Anti-Infective Drugs Market Overview; 11.1.2. Western Europe Anti-Infective Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.2. Western Europe Anti-Infective Drugs Market: Country Analysis; 11.3. UK Anti-Infective Drugs Market; 11.3.1. UK Anti-Infective Drugs Market Overview; 11.3.2. UK Anti-Infective Drugs Historic Market, 2012 - 2016; 11.3.3. UK Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.3.5. UK Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.4. Germany Anti-Infective Drugs Market; 11.4.1. Germany Anti-Infective Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.4.4 Germany Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.5 France Anti-Infective Drugs Market; 11.5.1 France Anti-Infective Drugs Historic Market, 2012 - 2016; 11.5.2 France Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.5.3 France Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.5.4 France Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.6. Italy Anti-Infective Drugs Market; 11.6.1. Italy Anti-Infective Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.6.4. Italy Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.7. Spain Anti-Infective Drugs Market; 11.7.1. Spain Anti-Infective Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.7.4. Spain Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Anti-Infective Drugs Market;
12.1.1. Eastern Europe Anti-Infective Drugs Market Overview; 12.1.2. Eastern Europe Anti-Infective Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Anti-Infective Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 12.2. Eastern Europe Anti-Infective Drugs Market: Country Analysis; 12.3. Russia Anti-Infective Drugs Market; 12.3.1. Russia Anti-Infective Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Anti-Infective Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Anti-Infective Drugs Market, 2016, By Segment; 12.3.3. Russia Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 12.3.4. Russia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;
13. North America Anti-Infective Drugs Market;
13.1.1. North America Anti-Infective Drugs Market Overview; 13.1.2. North America Anti-Infective Drugs Historic Market, 2012 - 2016; 13.1.3. North America Anti-Infective Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 13.2. North America Anti-Infective Drugs Market: Country Analysis; 13.3. USA Anti-Infective Drugs Market; 13.3.1. USA Anti-Infective Drugs Historic Market, 2012 - 2016; 13.3.2. USA Anti-Infective Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 13.3.4. USA Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;
14. South America Anti-Infective Drugs Market;
14.1.1. South America Anti-Infective Drugs Market Overview; 14.1.2. South America Anti-Infective Drugs Historic Market, 2012 - 2016; 14.1.3. South America Anti-Infective Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 14.2. South America Anti-Infective Drugs Market: Country Analysis; 14.3. Brazil Anti-Infective Drugs Market; 14.3.1. Brazil Anti-Infective Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Anti-Infective Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 14.3.4. Brazil Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;
15. Middle East Anti-Infective Drugs Market;
15.1.1. Middle East Anti-Infective Drugs Market Overview; 15.1.2. Middle East Anti-Infective Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Anti-Infective Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal);
16. Africa Anti-Infective Drugs Market;
16.1.1. Africa Anti-Infective Drugs Market Overview; 16.1.2. Africa Anti-Infective Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Anti-Infective Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal);
17. Anti-Infective Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Pfizer Inc.; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Glaxosmithkline; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Bristol-Myers Squibb Company; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Anti-Infective Drugs Market;
19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
20. Pharmaceuticals Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
2. Anti-Infective Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Anti-Infective Drugs Market Customer Information;
5. Anti-Infective Drugs Market Segmentation;
5.1. Global Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 5.2. Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Anti-Infective Drugs Market Trends And Strategies; 5.3 Global Anti-Infective Drugs Market Trends And Strategies;
6. Anti-Infective Drugs Market Regional And Country Analysis;
6.1. Global Anti-Infective Drugs Market, 2016, By Region; 6.2. Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Anti-Infective Drugs Market, 2016, By Country; 6.4. Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;
7. Global Anti-Infective Drugs Market Comparison With Macro Economic Factors;
7.1. Anti-Infective Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Anti-Infective Drugs Expenditure, Global;
8. Anti-Infective Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Anti-Infective Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Anti-Infective Drugs Expenditure, By Country;
9. Anti-Infective Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Anti-Infective Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Anti-Infective Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Anti-Infective Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Anti-Infective Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Hiv, 2014, By Country; 9.10. Global Number Of General Practitioners 2016, By Country; 9.11. Global Anti-Infective Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Anti-Infective Drugs Market;
10.1.1. Asia-Pacific Anti-Infective Drugs Market Overview; 10.1.2. Asia-Pacific Anti-Infective Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.2. Asia-Pacific Anti-Infective Drugs Market: Country Analysis; 10.3. China Anti-Infective Drugs Market; 10.3.1. China Anti-Infective Drugs Market Overview; 10.3.2. China Anti-Infective Drugs Historic Market, 2012 - 2016; 10.3.3. China Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.3.4. China Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.3.5. China Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 10.4. India Anti-Infective Drugs Market; 10.4.1. India Anti-Infective Drugs Market Overview; 10.4.2. India Anti-Infective Drugs Historic Market, 2012 - 2016; 10.4.3. India Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.4.4. India Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.4.5. India Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 10.5. Japan Anti-Infective Drugs Market; 10.5.1. Japan Anti-Infective Drugs Market Overview; 10.5.2. Japan Anti-Infective Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.5.5. Japan Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 10.6. Australia Anti-Infective Drugs Market; 10.6.1. Australia Anti-Infective Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.6.4. Australia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;
11. Western Europe Anti-Infective Drugs Market;
11.1.1. Western Europe Anti-Infective Drugs Market Overview; 11.1.2. Western Europe Anti-Infective Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.2. Western Europe Anti-Infective Drugs Market: Country Analysis; 11.3. UK Anti-Infective Drugs Market; 11.3.1. UK Anti-Infective Drugs Market Overview; 11.3.2. UK Anti-Infective Drugs Historic Market, 2012 - 2016; 11.3.3. UK Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.3.5. UK Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.4. Germany Anti-Infective Drugs Market; 11.4.1. Germany Anti-Infective Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.4.4 Germany Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.5 France Anti-Infective Drugs Market; 11.5.1 France Anti-Infective Drugs Historic Market, 2012 - 2016; 11.5.2 France Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.5.3 France Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.5.4 France Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.6. Italy Anti-Infective Drugs Market; 11.6.1. Italy Anti-Infective Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.6.4. Italy Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.7. Spain Anti-Infective Drugs Market; 11.7.1. Spain Anti-Infective Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.7.4. Spain Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;
12. Eastern Europe Anti-Infective Drugs Market;
12.1.1. Eastern Europe Anti-Infective Drugs Market Overview; 12.1.2. Eastern Europe Anti-Infective Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Anti-Infective Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 12.2. Eastern Europe Anti-Infective Drugs Market: Country Analysis; 12.3. Russia Anti-Infective Drugs Market; 12.3.1. Russia Anti-Infective Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Anti-Infective Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Anti-Infective Drugs Market, 2016, By Segment; 12.3.3. Russia Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 12.3.4. Russia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;
13. North America Anti-Infective Drugs Market;
13.1.1. North America Anti-Infective Drugs Market Overview; 13.1.2. North America Anti-Infective Drugs Historic Market, 2012 - 2016; 13.1.3. North America Anti-Infective Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 13.2. North America Anti-Infective Drugs Market: Country Analysis; 13.3. USA Anti-Infective Drugs Market; 13.3.1. USA Anti-Infective Drugs Historic Market, 2012 - 2016; 13.3.2. USA Anti-Infective Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 13.3.4. USA Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;
14. South America Anti-Infective Drugs Market;
14.1.1. South America Anti-Infective Drugs Market Overview; 14.1.2. South America Anti-Infective Drugs Historic Market, 2012 - 2016; 14.1.3. South America Anti-Infective Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 14.2. South America Anti-Infective Drugs Market: Country Analysis; 14.3. Brazil Anti-Infective Drugs Market; 14.3.1. Brazil Anti-Infective Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Anti-Infective Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 14.3.4. Brazil Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;
15. Middle East Anti-Infective Drugs Market;
15.1.1. Middle East Anti-Infective Drugs Market Overview; 15.1.2. Middle East Anti-Infective Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Anti-Infective Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal);
16. Africa Anti-Infective Drugs Market;
16.1.1. Africa Anti-Infective Drugs Market Overview; 16.1.2. Africa Anti-Infective Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Anti-Infective Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal);
17. Anti-Infective Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Pfizer Inc.; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Glaxosmithkline; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Bristol-Myers Squibb Company; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Anti-Infective Drugs Market;
19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;
20. Pharmaceuticals Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
